Blue Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Blue Trust's BMRN Position: Q3 2026 in Review
Blue Trust sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 1,029 shares — an estimated $58.9K sold.
Blue Trust first reported a position in BMRN in Q4 2022 and held it in 14 quarters. The position peaked at $70.7K in Q3 2024. 443 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Blue Trust reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 1,029 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $58.9K.
- Blue Trust first reported a position in BioMarin Pharmaceuticals in Q4 2022 and held it in 14 quarters.
- Blue Trust's BioMarin Pharmaceuticals position peaked at $70.7K in Q3 2024.
- 443 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.